Sold 242 shares
of Common Stock
at $31.56 per share
(Direct)
Date: 2025-09-02 |
Code: F
| equity_swap_involved: 0 | shares_owned_after: 26,963.00 | transaction_form_type: 4 | Footnotes: F1
Sold 325 shares
of Common Stock
at $31.56 per share
(Direct)
Date: 2025-09-02 |
Code: F
| equity_swap_involved: 0 | shares_owned_after: 26,638.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
F1: Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.
🔍 Cowan Elvia (Executive)
Company: Vaxcyte, Inc. (PCVX)
Report Date: 2025-09-02
Transaction Summary:
Detailed Transactions and Holdings:
Date: 2025-09-02 | Code: F | equity_swap_involved: 0 | shares_owned_after: 26,963.00 | transaction_form_type: 4 | Footnotes: F1
Date: 2025-09-02 | Code: F | equity_swap_involved: 0 | shares_owned_after: 26,638.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes: